This inventor holds 2 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: Virbac Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations of Jean-Pascal Marc
Introduction
Jean-Pascal Marc is a notable inventor based in Saint Paul de Vence, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating infections. With a total of two patents to his name, Marc's work is recognized for its potential impact on medical treatments.
Latest Patents
Marc's latest patents include innovative compounds that are designed to combat various infections. One of his patents focuses on amide derivatives of squalamine, which are used for the treatment of bacterial, fungal, viral, or parasitic infections. The compound of formula (I) is particularly noteworthy, as it includes a range of groups that enhance its effectiveness as a medicament. Additionally, he has developed compounds that are analogs of squalamine, which serve as antibacterial agents and have applications in treating cancer in both humans and animals.
Career Highlights
Throughout his career, Jean-Pascal Marc has been associated with Virbac Corporation, a company dedicated to animal health. His work at Virbac has allowed him to focus on innovative solutions for treating infections, contributing to advancements in veterinary medicine. His research has led to the development of pharmaceutical compositions that combine his compounds with other antibiotics, enhancing their therapeutic potential.
Collaborations
Marc has collaborated with several professionals in his field, including Jean-Michel Brunel and Marine Blanchet. These collaborations have fostered a productive environment for innovation and have contributed to the success of his research endeavors.
Conclusion
Jean-Pascal Marc's contributions to the field of pharmaceuticals highlight his commitment to developing effective treatments for infections. His innovative patents and collaborations reflect his dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
